An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT)

Molecular Genetics and Metabolism

Volumn 107, Issue 1-2, 2012, Pages 116-121

  Shapiro, Elsa ^a   Guler, O Evren ^b,f   Rudser, Kyle ^c   Delaney, Kathleen ^a   Bjoraker, Kendra ^a,g   Whitley, Chester ^a   Tolar, Jakub ^a   Orchard, Paul ^a   Provenzale, James ^d,e   Thomas, Kathleen M ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

^f AUGSBURG COLLEGE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

Author keywords

Attention span; Cognition; Diffusion tensor imaging; Hematopoietic cell transplant; Medical history; MPS I

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ARTICLE; ATTENTION; BRAIN FUNCTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; ENZYME REPLACEMENT; FEMALE; FRACTIONAL ANISOTROPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HURLER SYNDROME; INTELLIGENCE QUOTIENT; MALE; MEDICAL HISTORY; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BRAIN; CHILD; DIFFUSION TENSOR IMAGING; ENZYME REPLACEMENT THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS I; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866144416     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.07.016     Document Type: Article

References (35)

1. Boelens J., Prasad V., Tolar J., Wynn R., Peters C. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr. Clin. North. Am. 2010, 57:123-145.
2. Peters C., Balthazor M., Shapiro E.G., et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996, 87:4894-4902.
3. Peters C., Shapiro E.G., Anderson J., et al. Hurler syndrome: II Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998, 91:2601-2608.
4. Aldenhoven M., Boelens J.J., de Koning T.J. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol. Blood Marrow Transplant 2008, 14:485-498.
5. Anderson F.S., Kunin-Batson A.S., Perkins J.L., et al. White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood. Neuropsychiatr. Dis. Treat. 2008, 283-288.
6. Campbell L.K., Scaduto M., Sharp W., et al. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr. Blood Cancer 2007, 49:65-73.
7. Anderson F.S., Kunin-Batson A.S. Neurocognitive late effects of chemotherapy in children: the past 10years of research on brain structure and function. Pediatr. Blood Cancer 2009, 52:159-164.
8. Reddick W.E., Shan Z.Y., Glass J.O., et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006, 106:941-949.
9. Khong P.L., Leung L.H., Fung A.S., et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J. Clin. Oncol. 2006, 24:884-890.
10. Aukema E.J., Caan M.W., Nienke O., et al. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:837-843.
11. Bihan D., Mangin J.-F., Poupon C., et al. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13:534-546.
12. Mori S., Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006, 51:527-539.
13. MATLAB, The Mathworks, Inc., Natick, MA. http://www.mathworks.com.
14. DTI Studio, H. Jiang, S. Mori; John Hopkins University, Baltimore, MD; http://www.mristudio.org.
15. Gabrielli O., Polonara G., Regnicolo L., et al. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am. J. Med. Genet. 2004, 12:224-231.
16. Lee C., Dineen T.E., Brack M., et al. The mucopolysaccharidoses: characterization by cranial MR imaging. Am. J. Neuroradiol. 1993, 14:1285-1292.
17. Matheus G., Castillo M., Smith J.K., et al. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004, 46:666-672.
18. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999, NCS Pearson Inc., San Antonio, TX.
19. Greenberg L.M., Kindschi C. TOVA Test of Variables of Attention: Clinical Guide 1999, The TOVA Company, Los Alamitos, CA.
20. Benton A.L., de Hamsher K.S., Varney N.R., et al. Contributions to neuropsychological assessment 1983, Oxford University Press, New York.
21. Delis D., Kramer J.H., Kaplan E., et al. The California Verbal Learning Test-Childrens Edition Manual 1994, NCS Pearson Inc., San Antonio TX.
22. R Development Core Team R: A language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna Austria, URL http://www.r-project.org/.
23. Barnea-Goraly N., Menon V., Eckert M., et al. White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. Cereb. Cortex 2005, 15:1848-1854.
24. Muenzer J., Wraith J.E., Clarke L.A. Mucopolysaccharidosis I: management and treatment. Pediatrics 2009, 123:19-29. and The International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis I.
25. Shapiro E., Balthazor M. Metabolic and neurodegenerative disorders of childhood. Pediatric Neuropsychology: Research, Theory and Practice 2000, 171-205. Guilford Press, New York. G. Taylor, D. Ris, K. Yeates (Eds.).
26. Shapiro E. Risk factors contributing to neurolinguistic development following hematopoietic cell transplant in Hurler syndrome. Australian Society for the Study of Brain Impairment & International Neuropsychological Society (INS) Annual Meeting, Brisbane, Australia 2004.
27. Wraith J.E. The mucopolysaccharidoses: a clinical review and guide to management. Arch. Dis. Child. 1995, 72:263-267.
28. Muenzer J., Fisher A. Advances in the treatment of mucopolysaccharidosis type I. N. Engl. J. Med. 2004, 350:1932-1934.
29. Staba S.I., Escolar M.L., Poe M., et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N. Engl. J. Med. 2004, 350:1960-1969.
30. Souillet G., Guffon N., Maire I., et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 2003, 31:1105-1117.
31. Vijay S., Wraith J.E. Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005, 94:872-877.
32. Elkin T.D., Megason G., Robinson A., et al. Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome. Neuropsychiatr. Dis. Treat. 2006, 2:381-384.
33. Bjoraker K., Charnas L., Whitley C.B., et al. The natural history of cognitive abilities in Hurler-Scheie syndrome: eight years longitudinal evaluation of three siblings treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme®) 2005, Abstract, American Society of Human Genetics, Salt Lake City UT.
34. Bjoraker K., Delaney K., Peters C., et al. Long term outcomes of adaptive functions for children with MPS I. J. Dev. Behav. Pediatr. 2006, 27:290-296.
35. Lawrence Y.R., Li X.A., el Naqa I., et al. Radiation dose-volume effects in the brain. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:S20-S27.